Daniel Alencar Rodrigues

10PUBLICATIONS
22CO-AUTHORS
Characterisation of biological macromoleculesMolecular targetsHaematological tumoursBiomolecular modelling and designBiologically active molecules
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Jun 05, 2026
Identification of a mechanism-based binding mode for a histone deacetylase 6 inhibitor.

|Apr 26, 2026
Design, Synthesis, and Biological Evaluation of Novel Triazine-Based Dual Histone Deacetylase/phosphatidylinositol 3-kinase Inhibitors for Breast Cancer Therapy.

|Jul 28, 2025
Inhibition of HDAC6 alters fumarate hydratase activity and mitochondrial structure.

Andrew Roe, Catríona M Dowling, Cian D'Arcy

|Dec 08, 2022
The path to venetoclax resistance is paved with mutations, metabolism, and more.

Graeme P Sullivan, Lyndsey Flanagan, Daniel Alencar Rodrigues

|Aug 26, 2022
Design, Synthesis and Pharmacological Evaluation of Novel Conformationally Restricted N-arylpiperazine Derivatives Characterized as D2/D3 Receptor Ligands, Candidates for the Treatment of Neurodegenerative Diseases.

Thayssa Tavares da Silva Cunha, Rafaela Ribeiro Silva, Daniel Alencar Rodrigues

|Apr 30, 2021
Novel Single Inhibitor of HDAC6/8 and Dual Inhibitor of PI3K/HDAC6 as Potential Alternative Treatments for Prostate Cancer.

Fabiana Sélos Guerra, Daniel Alencar Rodrigues, Carlos Alberto Manssour Fraga

Pageof 2

Frequent Collaborators

6 joint publications

Carlos Alberto Manssour Fraga

3 joint publications

Pedro S M Pinheiro

3 joint publications

Tríona Ní Chonghaile

1 joint publications

Maria L Bolognesi